Latest News Archive
Please select Category, Year, and then Month to display items
01 September 2020
|
Story Dr Nitha Ramnath
|
Photo Supplied
The UFS’ Devina Harry was accepted into the Kader Asmal Fellowship Programme.
The UFS’ own Devina Harry is set to travel to Ireland in September 2020 to begin a year-long Fellowship Programme for a Master of Business. As one of 20 students selected from the African continent, Devina was recently accepted into the Kader Asmal Fellowship Programme, which affords her the opportunity to study in Ireland during the 2020/21 academic year.
A research assistant in the Department of Business Management, Devina holds an Honours in Marketing. “I am very grateful to be awarded this scholarship and excited about this new journey,” says Devina, who is scheduled to begin the programme in October 2020. “I hope to come back to South Africa and contribute to my field of study,” she says.
Devina went through a rigorous application process and had to meet the criteria for selection, one of which is having a minimum average grade point of 75% for her honours.
Prof Brownhilder Nene, Head of Department: Business Management, gave Devina some words of encouragement: “You will never know how far you can go unless you try. Thank you, Devina, for stepping out of your comfort zone and getting this scholarship.”
The Kader Asmal Fellowship Programme is a South African strand of a broader Ireland-Africa Fellows Programme managed by the
Irish Department of Foreign Affairs and Trade. It was set up in 2012 in honour of the late
Professor Kader Asmal, and is a fully-funded scholarship opportunity for those who want to develop skills and knowledge to contribute to the achievement of the Sustainable Development Goals in South Africa.
Otorhinolaryngology research hopes to decrease morbidity
2016-10-04
Prof Riaz Seedat, Head of the
Department of
Otorhinolaryngology at the UFS
Prof Riaz Seedat, Head of the Department of Otorhinolaryngology at the UFS is a world-renowned ear, nose and throat specialist and researcher. He is also a National Research Foundation C3 rated scientist.
He is conducting his research in ear, nose and throat (ENT) pathology in a developing world setting, particularly focusing on recurrent respiratory papillomatosis and other ENT conditions. “This condition is caused by human papillomavirus (HPV), infective conditions as well as allergic rhinitis,” said Prof Seedat.
Current research is aimed at further describing the epidemiology of recurrent respiratory papillomatosis, identification of the HPV variants responsible for causing the condition and markers of disease aggressiveness.
The research has led to various international partnerships such as the multicentre collaborative studies, “Genetic Susceptibility to Papilloma-induced Voice Disturbance” at the Centre for Genomic Sciences at the Allegheny-Singer Research Institute in Pittsburgh, United States, and the HPV6/11 Global Diversity Consortium at the University of Ljubljana in Slovenia.
Although most head and neck squamous cell carcinomas are caused by excessive tobacco and alcohol use, there is an increasing body of evidence to show that HPV causes a subset of head and neck squamous cell carcinomas. However, there are few studies on the role of HPV in head and neck neoplasms in developing countries.
“Through the research we have shown that recurrent respiratory papillomatosis, caused by HPV, is not as rare in South Africa as it is in developed countries and that patients usually present respiratory papillomatosis at an advanced stage when the condition is life-threatening,” said Prof Seedat.
“It is hoped that this research will help us to address the morbidity caused by ENT conditions common in developing countries,” said Prof Seedat.